Gallium-based metal–organic frameworks with antibacterial and anti-inflammatory properties for oral health protection DOI Creative Commons

Gongyuan Song,

Min Li, Bing Zhou

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 10(11), P. e31788 - e31788

Published: May 22, 2024

The fascial space of the oral and maxillofacial region contains loose connective tissues, which possess weak anti-infection ability are often prone to infection, leading acute suppurative inflammation sepsis through blood. Although antibiotic use can reduce probability bacterial infections, owing emergence antibiotic-resistant bacteria, search for new antimicrobial drugs is imminent. Herein, we report a metal-organic framework (MOF) antibacterial material designed synthesized with gallium (Ga) as central atom, possesses significant antibacterial, anti-inflammatory, antioxidant effects. Our data suggested that GA-based MOFs (Ga-MOFs; 1 μg/mL) could sufficiently kill

Language: Английский

Advances in Nanotechnology for Biofilm Inhibition DOI Creative Commons
Lokender Kumar, Monish Bisen, Kusum Harjai

et al.

ACS Omega, Journal Year: 2023, Volume and Issue: 8(24), P. 21391 - 21409

Published: June 7, 2023

Biofilm-associated infections have emerged as a significant public health challenge due to their persistent nature and increased resistance conventional treatment methods. The indiscriminate usage of antibiotics has made us susceptible range multidrug-resistant pathogens. These pathogens show reduced susceptibility intracellular survival. However, current methods for treating biofilms, such smart materials targeted drug delivery systems, not been found effective in preventing biofilm formation. To address this challenge, nanotechnology provided innovative solutions formation by clinically relevant Recent advances nanotechnological strategies, including metallic nanoparticles, functionalized dendrimers, polymeric cyclodextrin-based delivery, solid lipid polymer conjugates, liposomes, may provide valuable technological against infectious diseases. Therefore, it is imperative conduct comprehensive review summarize the recent advancements limitations advanced nanotechnologies. present Review encompasses summary agents, mechanisms that lead formation, impact on human health. In nutshell, offers survey managing infections. A detailed presentation how these strategies improve control prevent key objective mechanisms, applications, prospects nanotechnologies better understanding

Language: Английский

Citations

71

How biofilm changes our understanding of cleaning and disinfection DOI Creative Commons
Jean‐Yves Maillard, Isabella Centeleghe

Antimicrobial Resistance and Infection Control, Journal Year: 2023, Volume and Issue: 12(1)

Published: Sept. 7, 2023

Biofilms are ubiquitous in healthcare settings. By nature, biofilms less susceptible to antimicrobials and associated with healthcare-associated infections (HAI). Resistance of biofilm is multifactorial the presence a matrix composed extracellular polymeric substances eDNA, being major contributing factor. The usual multispecies composition environmental can also impact on antimicrobial efficacy. In settings, two main types present: hydrated biofilms, for example, drains parts some medical devices equipment, dry (DSB) surfaces possibly devices. act as reservoir pathogens including multi-drug resistant organisms their elimination requires different approaches. control (drain) should be informed by reduction or microbial bioburden together measuring regrowth time. DSB measured combination decrease bacterial transfer post-intervention. Failure increases risk HAI, but not solely responsible disinfection failure shortcoming. limited number standardised efficacy tests hindrance end users manufacturers, whilst Europe there no approved standard protocols. Education stakeholders about ad hoc tests, often academic thus paramount, achieve better

Language: Английский

Citations

46

Strategies to Promote the Journey of Nanoparticles Against Biofilm‐Associated Infections DOI
Xiaobo Wang, Dan Wang,

Hongwei Lu

et al.

Small, Journal Year: 2024, Volume and Issue: 20(10)

Published: Jan. 4, 2024

Abstract Biofilm‐associated infections are one of the most challenging healthcare threats for humans, accounting 80% bacterial infections, leading to persistent and chronic infections. The conventional antibiotics still face their dilemma poor therapeutic effects due high tolerance resistance led by biofilm barriers. Nanotechnology‐based antimicrobials, nanoparticles (NPs), paid attention extensively considered as promising alternative. This review focuses on whole journey NPs against biofilm‐associated clarify it clearly, is divided into four processes in sequence 1) Targeting biofilms, 2) Penetrating barrier, 3) Attaching cells, 4) Translocating through cell envelope. Through outlining compositions properties biofilms bacteria recent advances present strategies each process comprehensively discussed combat well combined these with drug resistance, aiming guide rational design facilitate wide application

Language: Английский

Citations

18

Nanocomposites against Pseudomonas aeruginosa biofilms: Recent advances, challenges, and future prospects DOI
Basma A. Omran, Boo Shan Tseng,

Kwang‐Hyun Baek

et al.

Microbiological Research, Journal Year: 2024, Volume and Issue: 282, P. 127656 - 127656

Published: Feb. 28, 2024

Language: Английский

Citations

14

Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice DOI Creative Commons
Fan Yang, Alireza Labani‐Motlagh, José Alejandro Bohórquez

et al.

Communications Biology, Journal Year: 2024, Volume and Issue: 7(1)

Published: March 9, 2024

The continuing emergence of new strains antibiotic-resistant bacteria has renewed interest in phage therapy; however, there been limited progress applying therapy to multi-drug resistant Mycobacterium tuberculosis (Mtb) infections. In this study, we show that bacteriophage D29 and DS6A can efficiently lyse Mtb H37Rv 7H10 agar plates. However, only kills liquid culture Mtb-infected human primary macrophages. We further subsequent experiments that, after the humanized mice were infected with aerosolized H37Rv, then treated intravenously, showed increased body weight improved pulmonary function relative control mice. Furthermore, reduces load mouse organs greater efficacy spleen. These results demonstrate feasibility developing as an effective therapeutic against infection.

Language: Английский

Citations

12

Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital DOI Creative Commons
Sara A. Alshaikh,

Tarek El-banna,

Fatma Sonbol

et al.

Annals of Clinical Microbiology and Antimicrobials, Journal Year: 2024, Volume and Issue: 23(1)

Published: Feb. 24, 2024

Abstract Background Uropathogenic Escherichia coli (UPEC) is the main etiological agent behind community-acquired and hospital-acquired urinary tract infections (UTIs), which are among most prevalent human infections. The management of UPEC becoming increasingly difficult owing to multi-drug resistance, biofilm formation, possession an extensive virulence arsenal. This study aims characterize isolates in Tanta, Egypt, with regard their antimicrobial phylogenetic profile, virulence, as well potential associations these factors. Methods One hundred were obtained from UTI patients Egypt. Antimicrobial susceptibility was assessed using Kirby-Bauer method. Extended-spectrum β-lactamases (ESBLs) production screened double disk synergy test confirmed PCR. Biofilm formation evaluated microtiter-plate assay microscopy-based techniques. groups determined. hemolytic activity, motility, siderophore production, serum resistance also evaluated. clonal relatedness ERIC-PCR. Results Isolates displayed elevated cephalosporins (90–43%), sulfamethoxazole-trimethoprim (63%), ciprofloxacin (53%). Ninety percent multidrug-resistant (MDR)/ extensively drug-resistant (XDR) 67% produced ESBLs. Notably, there inverse correlation between 31%, 29%, 32%, 8% strong, moderate, weak, non-biofilm producers, respectively. Beta-hemolysis, detected 64%, 84%, 65%, 11% isolates, Siderophore correlated multiple antibiotics, while hemolysis more susceptible associated stronger biofilms. Phylogroups B2 D predominated, lower biofilms group B2. ERIC-PCR revealed considerable diversity isolates. Conclusion research highlights dissemination evident suggests a cost on bacterial cells; that may rely enhance survival. emphasizes importance considering ability during treatment avoid therapeutic failure and/or infection recurrence.

Language: Английский

Citations

11

Nitric Oxide‐Actuated Titanium Dioxide Janus Nanoparticles for Enhanced Multimodal Disruption of Infectious Biofilms DOI
Weichen Zhao, Qihang Ding, Bingshuai Zhou

et al.

Advanced Functional Materials, Journal Year: 2024, Volume and Issue: 34(45)

Published: June 28, 2024

Abstract Sonodynamic therapy (SDT) is promising for combating deep‐seated infectious diseases by generating substantial reactive oxygen species (ROS) through the profound tissue penetration capabilities of ultrasound. However, compact protective structures bacterial biofilms present a formidable challenge, impeding ROS efficacy. Given that have limited diffusion range and current sonosensitizers struggle to infiltrate biofilms, complete eradication pathogenic bacteria often remains unachieved. In this study, mesoporous titanium dioxide (TiO 2 ) nanoparticles are engineered asymmetrically coated with thin layer Ag loaded L‐arginine (LA) construct ultrasound‐propelled nanomotors. These Ag‐TiO ‐LA Janus demonstrate robust self‐propulsion upon ultrasonic activation, allowing deeper into biofilm matrices enhancing localized disruption improved SDT outcomes. Additionally, incorporation not only broadens TiO ’s absorption spectrum but also confers photothermal NIR laser excitation at 808 nm. The nanomotor amalgamates sonodynamic potential Ag's properties, forging versatile antimicrobial agent capable efficient synergistic antibacterial effect when subjected dual ultrasound stimuli. This innovative, singularly‐structured nanoparticle stands out as an effective combatant against accelerates healing process infected wounds, showcasing multifaceted clinical applications.

Language: Английский

Citations

11

Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update DOI Creative Commons
Anil Philip Kunnath,

Mohamed Suodha Suoodh,

Dinesh Kumar Chellappan

et al.

British Journal of Biomedical Science, Journal Year: 2024, Volume and Issue: 81

Published: Aug. 7, 2024

The global issue of antimicrobial resistance poses significant challenges to public health. World Health Organization (WHO) has highlighted it as a major health threat, causing an estimated 700,000 deaths worldwide. Understanding the multifaceted nature antibiotic is crucial for developing effective strategies. Several physiological and biochemical mechanisms are involved in development resistance. Bacterial cells may escape bactericidal actions drugs by entering physiologically dormant state known bacterial persistence. Recent findings this field suggest that persistence can be one main sources chronic infections. tolerance developed persister could tolerate high levels antibiotics give rise offspring. These offspring attributed mechanisms, especially This review attempts shed light on persister-induced current therapeutic

Language: Английский

Citations

8

Biofilm antimicrobial susceptibility through an experimental evolutionary lens DOI Creative Commons
Tom Coenye, Mona Bové, Thomas Bjarnsholt

et al.

npj Biofilms and Microbiomes, Journal Year: 2022, Volume and Issue: 8(1)

Published: Oct. 18, 2022

Abstract Experimental evolution experiments in which bacterial populations are repeatedly exposed to an antimicrobial treatment, and examination of the genotype phenotype resulting evolved bacteria, can help shed light on mechanisms behind reduced susceptibility. In this review we present overview why it is important include biofilms experimental evolution, approaches available study what has taught us about tolerance resistance biofilms. Finally, emerging consensus view biofilm susceptibility supported by data obtained during studies.

Language: Английский

Citations

32

Targeted pH-responsive chitosan nanogels with Tanshinone IIA for enhancing the antibacterial/anti-biofilm efficacy DOI
Mingxia Wang,

Tariq Muhammad,

Huiling Gao

et al.

International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 237, P. 124177 - 124177

Published: March 25, 2023

Language: Английский

Citations

18